Board documents - Unitaid

⚲Search

English

Apply for funding

Who we are
Who we are
Learn more about our work and how we help accelerate the global health response.
About Unitaid
Strategy

Our organization

Work with us
What we do
What we do
Focus areas

HIV & coinfections

Tuberculosis

Malaria

Women's & children's health

Global health emergencies
Oxygen

Regional manufacturing

Climate and health

Cross-cutting priorities
Investments

Explore how our investments are shaping disease responses.
Learn more

Apply for funding

Financial grants to accelerate innovation in global health.
Learn more
Our impact

Our impact

Why Unitaid?

Learn more about the difference our work makes in the lives of people in low- and middle-income countries.
Learn more

Evaluations

External evaluations provide independent assessments of our work.

Learn more

Game-changing innovations

Explore the technologies and interventions we're working on.

Learn more
News & Events

News & events

News

All news News releases Stories Opinions Videos

In the media

See where our work is being mentioned in the media world.
Learn more

Press center

Resources for journalists and media representatives.
Learn more

All news

Call for PRC membership applications – February 2025

Unitaid remains committed to equitable access to critical health innovations

Spotlighting women’s health at the World Economic Forum

Learn more

News releases

Call for PRC membership applications – February 2025

New vector control tool effectively reduces malaria transmission in major clinical trial

Unitaid and Gavi establish new partnership to improve access to cervical cancer prevention  

Learn more

Stories

The last mile in child medicine: The best HIV medicines for the youngest babies

Kenya pioneers a new tool in the fight against malaria

From principle to practice: Involving communities in research design for effective hepatitis C prevention

Learn more

Opinions

Unitaid’s Early Market Access Vehicle – an innovative demand-driven model to catalyze introduction of new optimal health products in low- and middle-income countries

From promise to impact: Unlocking lenacapavir’s potential to end HIV

With antimicrobial resistance, women and children face highest risks

Learn more

Videos

Spotlighting women’s health at the World Economic Forum

Sally’s story: One woman’s fight against cervical cancer

COP29 spotlight: How Unitaid can reduce emissions in HIV treatment

Learn more
Publications

⚲

Board documents

Board meeting document
e-Resolutions
Key governance documents

15 October 2020

Board Meeting 36 Special Session

Special Session on the Selection of the Executive Director

17-18 June 2020

Board Meeting 35

Virtual meeting

Minutes:

Resoultions:

R1 - Renewal of the appointments of the Chair and members of the Proposal Review Committee

R2 - Unitaid 2019 audited financial statements

R3 - ACT-A Bridge Funding Mechanism

R4 - Mandate and Process for Unitaid’s involvement in the Access to COVID Technologies Accelerator

R5 - Code of Ethical Conduct for Unitaid Board Constituencies and Governance Officials

25 March 2020

Board Meeting 34 Special Session

Virtual meeting

Minutes:

Resolutions :

No resolutions adopted

20-21 November 2019

Board Meeting 33

Global Health Campus Geneva, Switzerland.

Minutes:

Resoultions:

R1 - Framework to pilot an agility mechanism

R2 - Review of key performance indicators

R3 - Area for Intervention malaria chemoprevention, focus on IPTi

R4 - Unitaid Budget 2020

R5 - Appointment of PSC and FAC chairs and vice-chairs

R6 - Appointment of PSC and FAC members

R7 - Appointment of GWG Chair and members

R8 - Amendment to the Board Operating Procedures

19-20 June 2019

Board Meeting 32

The Plaza Hotel Seoul, Republic of Korea.

Minutes:

Resoultions:

R1 - Unitaid 2018 Audited Financial Statements

R2 - Liquidity Policy

R3 - Foreign Exchange Risk Mitigation Policy

R4 - Report of the 2017-2021 Midterm Strategy Review

R5 - Updated terms of reference of FAC and PSC

R6 - Calendar of 2019 and 2020 Board and Committee meetings dates

R7 - Election of the Board Vice-Chair

R8 - Vote of thanks to outgoing Chair and Welcome to new Chair

R9 - Unitaid Board Evolution

28 May 2019

Board Meeting 31 Special Session

Global Health Campus Geneva, Switzerland.

Resoultions:

R1 - Election of the Executive Board Chair

05-06 December 2018

Board Meeting 30

Radisson Blu Hotel Marrakech, Morocco.

Minutes:

Resoultions:

R1 - Approval of the 2019 Unitaid budget

R2 - Unitaid Risk Management Policy

R3 - Area for Intervention: Accelerating impact of long-acting technologies in low and middle-income countries

R4 - Area for Intervention: Better tools for the diagnosis and treatment of Plasmodium vivax malaria

R5 - Launch of the Board Chair selection process

R6 - Extension of the mandate of the Vice-Chair

R7 - Governance Working Group Extension of mandate

R8 - Revised Calendar of Board and Committee meetings for 2019

21 June 2018

Board Meeting 29

Villa du Lac Divonne-les-Bains, France.

Minutes:

Resoultions:

R1 - Unitaid 2017 Audited Financial Statements

R2 - Board Operating Procedures

R3 - Extension of the Vice-Chair’s mandate

R4 - Seat of the Republic of Korea in the Unitaid Executive Board

R5 - Creation of a GWG sub-group on the approach to the management of Board declarations of interests

1 2 3 4 … 6

2013
2014
2015
2016
2017
2018
2019
2020
2021
2022
2023
2024
2025

2024

May

R13-2024-e

Amendment to WHO Enabler Grant

April

R12-2024-e

Amended Calendar of Board and Committee meetings for 2024

February

R11-2024-e

Acceptance of a Specified Contribution from the European Commission and expansion of investments in new tools to reduce maternal mortality

R10-2024-e

“East Africa Program on Oxygen Access (EAPOA)”

January

R9-2024-e

Cost Extension for the Project “Global long-acting drug combination development” (GLAD)

R8-2024-e

Cost Extension for the Project “Long-acting pipeline to establish medicines for malaria, tuberculosis and hepatitis C virus with infrastructure for sustainable translational capacity (LONGEVITY)”

R7-2024-e

Cost Extension for the Project “Long-acting injectable formulation of ivermectin as a new vector control tool to reduce malaria transmission” (IMPACT)

R6-2024-e

Go-ahead for the development of grant agreement packages on Mitigating Antimalarial Drug Resistance for proposed project with Jhpiego Corporation

1 2 3 4 … 27

No posts found.

Sign up for Unitaid updates

First Name

Last Name

Email

Contact us

Connect

Apply for funding
Careers
Report fraud or abuse

Useful links

About Unitaid
Executive Board
Projects
Why Unitaid?

Game-changing innovations
Publications
News
Events

Email scams
Privacy policy

Follow us on social media

© World Health Organization. All rights reserved 2025. Unitaid is a hosted partnership of the World Health Organization.